Trials / Completed
CompletedNCT01691820
A Study in Adolescent Females to Explore Cytomegalovirus Infection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 369 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Female
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to estimate the incidence of Cytomegalovirus (CMV) secondary infections (re-infections/re-activations) and the incidence of CMV primary infections in adolescent females.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood collection | Samples collected at Months 0, 4, 8, 12, 16, 20, 24, 28, 32, and 36. |
| PROCEDURE | Urine collection | Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36. |
| PROCEDURE | Saliva collection | Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36. |
Timeline
- Start date
- 2012-10-05
- Primary completion
- 2017-04-08
- Completion
- 2017-04-08
- First posted
- 2012-09-25
- Last updated
- 2021-04-27
- Results posted
- 2019-01-25
Locations
5 sites across 3 countries: United States, Finland, Mexico
Source: ClinicalTrials.gov record NCT01691820. Inclusion in this directory is not an endorsement.